<DOC>
	<DOC>NCT02632149</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical effectiveness of PINS vagus nerve stimulatior in children with Lennox-Gastaut Syndrome.</brief_summary>
	<brief_title>Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<criteria>1. Age 314 year 2. Lennox Gastaut syndrome diagnostic standard 3. Regular drug treatment is invalid 4. Antiepileptic drug stability in recent 3 months 5. Good health except epilepsy 6. Patients or his(her) familyscould understand this method and sign the informed consent 7. Patients with good compliance and could complete postoperative followup. 1. Results of MRI remind epilepsy caused by intracranial spaceoccupying lesions 2. Had epileptic foci excision surgery or corpus callosum 3. The vagus nerve lesion and damage 4. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma， mental disease，peptic ulcer，diabetes Type 1，bad health etc, and other surgical contraindication 5. Participated in other clinical drug test subjects within three months 6. The researchers think that is not suitable for participants'</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PINS Vagus Nerve Stimulator</keyword>
</DOC>